nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—CYP3A4—Temozolomide—melanoma	0.201	0.385	CbGbCtD
Hydrocodone—CYP2D6—Vemurafenib—melanoma	0.173	0.332	CbGbCtD
Hydrocodone—CYP3A4—Vemurafenib—melanoma	0.11	0.211	CbGbCtD
Hydrocodone—CYP3A4—Docetaxel—melanoma	0.0378	0.0724	CbGbCtD
Hydrocodone—Non-cardiac chest pain—Docetaxel—melanoma	0.0124	0.0457	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Vemurafenib—melanoma	0.00641	0.0236	CcSEcCtD
Hydrocodone—Naloxone—TLR4—melanoma	0.00514	0.628	CrCbGaD
Hydrocodone—Pain in extremity—Vemurafenib—melanoma	0.00459	0.0169	CcSEcCtD
Hydrocodone—Drug interaction—Carmustine—melanoma	0.00361	0.0133	CcSEcCtD
Hydrocodone—Hearing impaired—Temozolomide—melanoma	0.0034	0.0125	CcSEcCtD
Hydrocodone—Neck pain—Carmustine—melanoma	0.00339	0.0125	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Temozolomide—melanoma	0.00327	0.0121	CcSEcCtD
Hydrocodone—Oedema peripheral—Vemurafenib—melanoma	0.00313	0.0115	CcSEcCtD
Hydrocodone—Connective tissue disorder—Vemurafenib—melanoma	0.00312	0.0115	CcSEcCtD
Hydrocodone—Angiopathy—Vemurafenib—melanoma	0.00288	0.0106	CcSEcCtD
Hydrocodone—Mediastinal disorder—Vemurafenib—melanoma	0.00286	0.0106	CcSEcCtD
Hydrocodone—Malnutrition—Vemurafenib—melanoma	0.00277	0.0102	CcSEcCtD
Hydrocodone—Back pain—Vemurafenib—melanoma	0.00268	0.00987	CcSEcCtD
Hydrocodone—Lethargy—Dactinomycin—melanoma	0.00265	0.00977	CcSEcCtD
Hydrocodone—Deafness—Temozolomide—melanoma	0.00262	0.00968	CcSEcCtD
Hydrocodone—Hot flush—Temozolomide—melanoma	0.00251	0.00925	CcSEcCtD
Hydrocodone—Menopausal symptoms—Temozolomide—melanoma	0.00249	0.00917	CcSEcCtD
Hydrocodone—Cough—Vemurafenib—melanoma	0.00241	0.0089	CcSEcCtD
Hydrocodone—Myalgia—Vemurafenib—melanoma	0.00236	0.00868	CcSEcCtD
Hydrocodone—Arthralgia—Vemurafenib—melanoma	0.00236	0.00868	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00234	0.00862	CcSEcCtD
Hydrocodone—Drug interaction—Docetaxel—melanoma	0.00232	0.00855	CcSEcCtD
Hydrocodone—Affect lability—Temozolomide—melanoma	0.00231	0.00852	CcSEcCtD
Hydrocodone—Hearing impaired—Docetaxel—melanoma	0.00226	0.00833	CcSEcCtD
Hydrocodone—Mood swings—Temozolomide—melanoma	0.00222	0.0082	CcSEcCtD
Hydrocodone—Nervous system disorder—Vemurafenib—melanoma	0.00221	0.00816	CcSEcCtD
Hydrocodone—Hypokalaemia—Carmustine—melanoma	0.00221	0.00815	CcSEcCtD
Hydrocodone—Skin disorder—Vemurafenib—melanoma	0.00219	0.00809	CcSEcCtD
Hydrocodone—Dehydration—Temozolomide—melanoma	0.00218	0.00805	CcSEcCtD
Hydrocodone—Hypokalaemia—Temozolomide—melanoma	0.00214	0.00788	CcSEcCtD
Hydrocodone—Hypotension—Vemurafenib—melanoma	0.00211	0.00778	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00206	0.00758	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Vemurafenib—melanoma	0.00195	0.00719	CcSEcCtD
Hydrocodone—Fatigue—Vemurafenib—melanoma	0.00195	0.00718	CcSEcCtD
Hydrocodone—Constipation—Vemurafenib—melanoma	0.00193	0.00712	CcSEcCtD
Hydrocodone—Lightheadedness—Docetaxel—melanoma	0.00192	0.00709	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Temozolomide—melanoma	0.00189	0.00695	CcSEcCtD
Hydrocodone—Agranulocytosis—Dactinomycin—melanoma	0.00187	0.00688	CcSEcCtD
Hydrocodone—Urinary tract infection—Carmustine—melanoma	0.00182	0.00671	CcSEcCtD
Hydrocodone—Body temperature increased—Vemurafenib—melanoma	0.00178	0.00658	CcSEcCtD
Hydrocodone—Urinary tract infection—Temozolomide—melanoma	0.00176	0.00648	CcSEcCtD
Hydrocodone—Deafness—Docetaxel—melanoma	0.00175	0.00643	CcSEcCtD
Hydrocodone—Hot flush—Docetaxel—melanoma	0.00167	0.00615	CcSEcCtD
Hydrocodone—Hypersensitivity—Vemurafenib—melanoma	0.00166	0.00613	CcSEcCtD
Hydrocodone—Oedema peripheral—Carmustine—melanoma	0.00166	0.0061	CcSEcCtD
Hydrocodone—Menopausal symptoms—Docetaxel—melanoma	0.00165	0.0061	CcSEcCtD
Hydrocodone—Connective tissue disorder—Carmustine—melanoma	0.00165	0.00609	CcSEcCtD
Hydrocodone—Asthenia—Vemurafenib—melanoma	0.00162	0.00597	CcSEcCtD
Hydrocodone—Oedema peripheral—Temozolomide—melanoma	0.0016	0.0059	CcSEcCtD
Hydrocodone—Pruritus—Vemurafenib—melanoma	0.0016	0.00589	CcSEcCtD
Hydrocodone—Connective tissue disorder—Temozolomide—melanoma	0.0016	0.00588	CcSEcCtD
Hydrocodone—Lethargy—Docetaxel—melanoma	0.00159	0.00587	CcSEcCtD
Hydrocodone—Pain in extremity—Docetaxel—melanoma	0.00156	0.00576	CcSEcCtD
Hydrocodone—Migraine—Docetaxel—melanoma	0.00154	0.00567	CcSEcCtD
Hydrocodone—Dizziness—Vemurafenib—melanoma	0.00149	0.0055	CcSEcCtD
Hydrocodone—Angiopathy—Temozolomide—melanoma	0.00147	0.00543	CcSEcCtD
Hydrocodone—Mental disorder—Carmustine—melanoma	0.00147	0.00543	CcSEcCtD
Hydrocodone—Mediastinal disorder—Temozolomide—melanoma	0.00146	0.0054	CcSEcCtD
Hydrocodone—Malnutrition—Carmustine—melanoma	0.00146	0.00539	CcSEcCtD
Hydrocodone—Cough—Bleomycin—melanoma	0.00146	0.00539	CcSEcCtD
Hydrocodone—Dehydration—Docetaxel—melanoma	0.00145	0.00535	CcSEcCtD
Hydrocodone—Vomiting—Vemurafenib—melanoma	0.00144	0.00529	CcSEcCtD
Hydrocodone—Myalgia—Bleomycin—melanoma	0.00143	0.00526	CcSEcCtD
Hydrocodone—Rash—Vemurafenib—melanoma	0.00142	0.00525	CcSEcCtD
Hydrocodone—Mental disorder—Temozolomide—melanoma	0.00142	0.00525	CcSEcCtD
Hydrocodone—Dermatitis—Vemurafenib—melanoma	0.00142	0.00524	CcSEcCtD
Hydrocodone—Back pain—Carmustine—melanoma	0.00142	0.00522	CcSEcCtD
Hydrocodone—Headache—Vemurafenib—melanoma	0.00141	0.00521	CcSEcCtD
Hydrocodone—Malnutrition—Temozolomide—melanoma	0.00141	0.00521	CcSEcCtD
Hydrocodone—Tremor—Carmustine—melanoma	0.00137	0.00505	CcSEcCtD
Hydrocodone—Back pain—Temozolomide—melanoma	0.00137	0.00504	CcSEcCtD
Hydrocodone—Nausea—Vemurafenib—melanoma	0.00134	0.00494	CcSEcCtD
Hydrocodone—Thrombocytopenia—Bleomycin—melanoma	0.00134	0.00494	CcSEcCtD
Hydrocodone—Myalgia—Dactinomycin—melanoma	0.00133	0.00491	CcSEcCtD
Hydrocodone—Tremor—Temozolomide—melanoma	0.00132	0.00488	CcSEcCtD
Hydrocodone—Hypotension—Bleomycin—melanoma	0.00128	0.00471	CcSEcCtD
Hydrocodone—Convulsion—Carmustine—melanoma	0.00127	0.00467	CcSEcCtD
Hydrocodone—Thrombocytopenia—Dactinomycin—melanoma	0.00125	0.00461	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Bleomycin—melanoma	0.00125	0.00459	CcSEcCtD
Hydrocodone—Myalgia—Carmustine—melanoma	0.00125	0.00459	CcSEcCtD
Hydrocodone—Anxiety—Carmustine—melanoma	0.00124	0.00458	CcSEcCtD
Hydrocodone—Cough—Temozolomide—melanoma	0.00123	0.00455	CcSEcCtD
Hydrocodone—Paraesthesia—Bleomycin—melanoma	0.00123	0.00453	CcSEcCtD
Hydrocodone—Convulsion—Temozolomide—melanoma	0.00123	0.00452	CcSEcCtD
Hydrocodone—Dyspnoea—Bleomycin—melanoma	0.00122	0.0045	CcSEcCtD
Hydrocodone—Arthralgia—Temozolomide—melanoma	0.0012	0.00444	CcSEcCtD
Hydrocodone—Myalgia—Temozolomide—melanoma	0.0012	0.00444	CcSEcCtD
Hydrocodone—Anxiety—Temozolomide—melanoma	0.0012	0.00442	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.0012	0.00441	CcSEcCtD
Hydrocodone—Dry mouth—Temozolomide—melanoma	0.00118	0.00434	CcSEcCtD
Hydrocodone—Thrombocytopenia—Carmustine—melanoma	0.00117	0.00431	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00116	0.00429	CcSEcCtD
Hydrocodone—Nervous system disorder—Temozolomide—melanoma	0.00113	0.00417	CcSEcCtD
Hydrocodone—Thrombocytopenia—Temozolomide—melanoma	0.00113	0.00417	CcSEcCtD
Hydrocodone—Agranulocytosis—Docetaxel—melanoma	0.00112	0.00414	CcSEcCtD
Hydrocodone—Skin disorder—Temozolomide—melanoma	0.00112	0.00413	CcSEcCtD
Hydrocodone—Hypotension—Carmustine—melanoma	0.00112	0.00411	CcSEcCtD
Hydrocodone—Hyperhidrosis—Temozolomide—melanoma	0.00112	0.00411	CcSEcCtD
Hydrocodone—Fatigue—Dactinomycin—melanoma	0.0011	0.00406	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Carmustine—melanoma	0.00109	0.00401	CcSEcCtD
Hydrocodone—Body temperature increased—Bleomycin—melanoma	0.00108	0.00399	CcSEcCtD
Hydrocodone—Insomnia—Carmustine—melanoma	0.00108	0.00398	CcSEcCtD
Hydrocodone—Paraesthesia—Carmustine—melanoma	0.00107	0.00395	CcSEcCtD
Hydrocodone—Dyspnoea—Carmustine—melanoma	0.00106	0.00392	CcSEcCtD
Hydrocodone—Oedema peripheral—Docetaxel—melanoma	0.00106	0.00392	CcSEcCtD
Hydrocodone—Somnolence—Carmustine—melanoma	0.00106	0.00391	CcSEcCtD
Hydrocodone—Connective tissue disorder—Docetaxel—melanoma	0.00106	0.00391	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Temozolomide—melanoma	0.00105	0.00388	CcSEcCtD
Hydrocodone—Insomnia—Temozolomide—melanoma	0.00104	0.00385	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Dactinomycin—melanoma	0.00104	0.00385	CcSEcCtD
Hydrocodone—Paraesthesia—Temozolomide—melanoma	0.00104	0.00382	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Carmustine—melanoma	0.00103	0.0038	CcSEcCtD
Hydrocodone—Dyspnoea—Temozolomide—melanoma	0.00103	0.00379	CcSEcCtD
Hydrocodone—Somnolence—Temozolomide—melanoma	0.00103	0.00378	CcSEcCtD
Hydrocodone—Constipation—Carmustine—melanoma	0.00102	0.00376	CcSEcCtD
Hydrocodone—Abdominal pain—Dactinomycin—melanoma	0.00101	0.00372	CcSEcCtD
Hydrocodone—Body temperature increased—Dactinomycin—melanoma	0.00101	0.00372	CcSEcCtD
Hydrocodone—Hypersensitivity—Bleomycin—melanoma	0.00101	0.00372	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Temozolomide—melanoma	0.000996	0.00367	CcSEcCtD
Hydrocodone—Fatigue—Temozolomide—melanoma	0.000995	0.00367	CcSEcCtD
Hydrocodone—Constipation—Temozolomide—melanoma	0.000987	0.00364	CcSEcCtD
Hydrocodone—Asthenia—Bleomycin—melanoma	0.000981	0.00362	CcSEcCtD
Hydrocodone—Angiopathy—Docetaxel—melanoma	0.00098	0.00361	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Carmustine—melanoma	0.000976	0.0036	CcSEcCtD
Hydrocodone—Mediastinal disorder—Docetaxel—melanoma	0.000973	0.00359	CcSEcCtD
Hydrocodone—Pruritus—Bleomycin—melanoma	0.000968	0.00357	CcSEcCtD
Hydrocodone—Mental disorder—Docetaxel—melanoma	0.000946	0.00349	CcSEcCtD
Hydrocodone—Abdominal pain—Carmustine—melanoma	0.000944	0.00348	CcSEcCtD
Hydrocodone—Body temperature increased—Carmustine—melanoma	0.000944	0.00348	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Temozolomide—melanoma	0.000944	0.00348	CcSEcCtD
Hydrocodone—Malnutrition—Docetaxel—melanoma	0.00094	0.00347	CcSEcCtD
Hydrocodone—Hypersensitivity—Dactinomycin—melanoma	0.00094	0.00347	CcSEcCtD
Hydrocodone—Asthenia—Dactinomycin—melanoma	0.000915	0.00337	CcSEcCtD
Hydrocodone—Abdominal pain—Temozolomide—melanoma	0.000912	0.00336	CcSEcCtD
Hydrocodone—Body temperature increased—Temozolomide—melanoma	0.000912	0.00336	CcSEcCtD
Hydrocodone—Back pain—Docetaxel—melanoma	0.00091	0.00335	CcSEcCtD
Hydrocodone—Muscle spasms—Docetaxel—melanoma	0.000904	0.00333	CcSEcCtD
Hydrocodone—Hypersensitivity—Carmustine—melanoma	0.00088	0.00324	CcSEcCtD
Hydrocodone—Vomiting—Bleomycin—melanoma	0.00087	0.00321	CcSEcCtD
Hydrocodone—Rash—Bleomycin—melanoma	0.000863	0.00318	CcSEcCtD
Hydrocodone—Dermatitis—Bleomycin—melanoma	0.000862	0.00318	CcSEcCtD
Hydrocodone—Asthenia—Carmustine—melanoma	0.000857	0.00316	CcSEcCtD
Hydrocodone—Hypersensitivity—Temozolomide—melanoma	0.00085	0.00313	CcSEcCtD
Hydrocodone—Naltrexone—ABCB1—melanoma	0.00084	0.103	CrCbGaD
Hydrocodone—Asthenia—Temozolomide—melanoma	0.000828	0.00305	CcSEcCtD
Hydrocodone—Cough—Docetaxel—melanoma	0.000821	0.00302	CcSEcCtD
Hydrocodone—Pruritus—Temozolomide—melanoma	0.000816	0.00301	CcSEcCtD
Hydrocodone—Convulsion—Docetaxel—melanoma	0.000815	0.003	CcSEcCtD
Hydrocodone—Nausea—Bleomycin—melanoma	0.000813	0.003	CcSEcCtD
Hydrocodone—Vomiting—Dactinomycin—melanoma	0.000811	0.00299	CcSEcCtD
Hydrocodone—Rash—Dactinomycin—melanoma	0.000804	0.00297	CcSEcCtD
Hydrocodone—Myalgia—Docetaxel—melanoma	0.000801	0.00295	CcSEcCtD
Hydrocodone—Arthralgia—Docetaxel—melanoma	0.000801	0.00295	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000795	0.00293	CcSEcCtD
Hydrocodone—Dizziness—Carmustine—melanoma	0.00079	0.00291	CcSEcCtD
Hydrocodone—Dry mouth—Docetaxel—melanoma	0.000783	0.00289	CcSEcCtD
Hydrocodone—Dizziness—Temozolomide—melanoma	0.000763	0.00281	CcSEcCtD
Hydrocodone—Vomiting—Carmustine—melanoma	0.000759	0.0028	CcSEcCtD
Hydrocodone—Nausea—Dactinomycin—melanoma	0.000758	0.00279	CcSEcCtD
Hydrocodone—Rash—Carmustine—melanoma	0.000753	0.00278	CcSEcCtD
Hydrocodone—Nervous system disorder—Docetaxel—melanoma	0.000753	0.00277	CcSEcCtD
Hydrocodone—Dermatitis—Carmustine—melanoma	0.000752	0.00277	CcSEcCtD
Hydrocodone—Thrombocytopenia—Docetaxel—melanoma	0.000751	0.00277	CcSEcCtD
Hydrocodone—Headache—Carmustine—melanoma	0.000748	0.00276	CcSEcCtD
Hydrocodone—Skin disorder—Docetaxel—melanoma	0.000745	0.00275	CcSEcCtD
Hydrocodone—Vomiting—Temozolomide—melanoma	0.000734	0.0027	CcSEcCtD
Hydrocodone—Rash—Temozolomide—melanoma	0.000728	0.00268	CcSEcCtD
Hydrocodone—Dermatitis—Temozolomide—melanoma	0.000727	0.00268	CcSEcCtD
Hydrocodone—Headache—Temozolomide—melanoma	0.000723	0.00267	CcSEcCtD
Hydrocodone—Hypotension—Docetaxel—melanoma	0.000717	0.00264	CcSEcCtD
Hydrocodone—Nausea—Carmustine—melanoma	0.000709	0.00261	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Docetaxel—melanoma	0.000699	0.00258	CcSEcCtD
Hydrocodone—Insomnia—Docetaxel—melanoma	0.000694	0.00256	CcSEcCtD
Hydrocodone—Paraesthesia—Docetaxel—melanoma	0.000689	0.00254	CcSEcCtD
Hydrocodone—Nausea—Temozolomide—melanoma	0.000685	0.00253	CcSEcCtD
Hydrocodone—Dyspnoea—Docetaxel—melanoma	0.000684	0.00252	CcSEcCtD
Hydrocodone—Somnolence—Docetaxel—melanoma	0.000682	0.00252	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Docetaxel—melanoma	0.000663	0.00244	CcSEcCtD
Hydrocodone—Fatigue—Docetaxel—melanoma	0.000662	0.00244	CcSEcCtD
Hydrocodone—Constipation—Docetaxel—melanoma	0.000656	0.00242	CcSEcCtD
Hydrocodone—Naloxone—ALB—melanoma	0.000642	0.0784	CrCbGaD
Hydrocodone—Gastrointestinal pain—Docetaxel—melanoma	0.000628	0.00231	CcSEcCtD
Hydrocodone—Naloxone—ABCB1—melanoma	0.000613	0.0748	CrCbGaD
Hydrocodone—Body temperature increased—Docetaxel—melanoma	0.000607	0.00224	CcSEcCtD
Hydrocodone—Abdominal pain—Docetaxel—melanoma	0.000607	0.00224	CcSEcCtD
Hydrocodone—Hypersensitivity—Docetaxel—melanoma	0.000565	0.00208	CcSEcCtD
Hydrocodone—Asthenia—Docetaxel—melanoma	0.000551	0.00203	CcSEcCtD
Hydrocodone—Pruritus—Docetaxel—melanoma	0.000543	0.002	CcSEcCtD
Hydrocodone—Morphine—ABCB1—melanoma	0.000518	0.0632	CrCbGaD
Hydrocodone—Dizziness—Docetaxel—melanoma	0.000507	0.00187	CcSEcCtD
Hydrocodone—Vomiting—Docetaxel—melanoma	0.000488	0.0018	CcSEcCtD
Hydrocodone—Rash—Docetaxel—melanoma	0.000484	0.00178	CcSEcCtD
Hydrocodone—Dermatitis—Docetaxel—melanoma	0.000483	0.00178	CcSEcCtD
Hydrocodone—Headache—Docetaxel—melanoma	0.000481	0.00177	CcSEcCtD
Hydrocodone—Nausea—Docetaxel—melanoma	0.000456	0.00168	CcSEcCtD
Hydrocodone—Dextromethorphan—ABCB1—melanoma	0.000435	0.053	CrCbGaD
Hydrocodone—OPRM1—Signaling Pathways—NGFR—melanoma	5.36e-05	0.00027	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EDN1—melanoma	5.32e-05	0.000268	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL2—melanoma	5.31e-05	0.000268	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TERT—melanoma	5.29e-05	0.000267	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RAC1—melanoma	5.27e-05	0.000266	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CSF2—melanoma	5.2e-05	0.000262	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FGF1—melanoma	5.2e-05	0.000262	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—IL2—melanoma	5.13e-05	0.000259	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—E2F1—melanoma	5.09e-05	0.000257	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CB—melanoma	5.07e-05	0.000256	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HIF1A—melanoma	5.06e-05	0.000255	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PDGFRA—melanoma	5.04e-05	0.000254	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ITGB3—melanoma	4.99e-05	0.000252	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PRKCA—melanoma	4.99e-05	0.000252	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SOCS1—melanoma	4.96e-05	0.00025	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—MAP2K1—melanoma	4.95e-05	0.00025	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—S100B—melanoma	4.95e-05	0.000249	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CD—melanoma	4.91e-05	0.000248	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SPP1—melanoma	4.89e-05	0.000247	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAP2K2—melanoma	4.88e-05	0.000246	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CXCL8—melanoma	4.87e-05	0.000246	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KDR—melanoma	4.84e-05	0.000244	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PLCB4—melanoma	4.83e-05	0.000244	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ERBB4—melanoma	4.73e-05	0.000239	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CB—melanoma	4.72e-05	0.000238	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CDKN2B—melanoma	4.69e-05	0.000236	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FN1—melanoma	4.66e-05	0.000235	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL2—melanoma	4.65e-05	0.000235	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TERT—melanoma	4.64e-05	0.000234	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RAC1—melanoma	4.63e-05	0.000233	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PLA2G6—melanoma	4.61e-05	0.000233	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NOTCH1—melanoma	4.56e-05	0.00023	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC6A11—melanoma	4.54e-05	0.000229	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIP4K2A—melanoma	4.54e-05	0.000229	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CD86—melanoma	4.54e-05	0.000229	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCL8—melanoma	4.53e-05	0.000229	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EDN1—melanoma	4.5e-05	0.000227	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CD80—melanoma	4.46e-05	0.000225	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—APC—melanoma	4.46e-05	0.000225	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CG—melanoma	4.46e-05	0.000225	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KIT—melanoma	4.46e-05	0.000225	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—NRAS—melanoma	4.46e-05	0.000225	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HIF1A—melanoma	4.44e-05	0.000224	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTAP—melanoma	4.42e-05	0.000223	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EGF—melanoma	4.4e-05	0.000222	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGF1—melanoma	4.4e-05	0.000222	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CSF2—melanoma	4.4e-05	0.000222	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—IL2—melanoma	4.33e-05	0.000218	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—E2F1—melanoma	4.3e-05	0.000217	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CB—melanoma	4.28e-05	0.000216	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—MAPK3—melanoma	4.27e-05	0.000215	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PDGFRA—melanoma	4.26e-05	0.000215	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KDR—melanoma	4.24e-05	0.000214	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ITGB3—melanoma	4.22e-05	0.000213	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PRKCA—melanoma	4.22e-05	0.000213	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—BRAF—melanoma	4.19e-05	0.000211	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—VCAN—melanoma	4.14e-05	0.000209	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SPP1—melanoma	4.13e-05	0.000209	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAP2K2—melanoma	4.12e-05	0.000208	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CXCL8—melanoma	4.12e-05	0.000208	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FN1—melanoma	4.08e-05	0.000206	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IGF1—melanoma	4.08e-05	0.000206	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—MAPK1—melanoma	4.06e-05	0.000205	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—EGFR—melanoma	4.06e-05	0.000205	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOTCH1—melanoma	4e-05	0.000202	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAP2K1—melanoma	3.94e-05	0.000199	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PHGDH—melanoma	3.94e-05	0.000199	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LUM—melanoma	3.94e-05	0.000199	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL2—melanoma	3.93e-05	0.000198	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TERT—melanoma	3.92e-05	0.000198	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CD—melanoma	3.92e-05	0.000198	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CD80—melanoma	3.91e-05	0.000197	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RAC1—melanoma	3.91e-05	0.000197	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KIT—melanoma	3.91e-05	0.000197	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CG—melanoma	3.91e-05	0.000197	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—APC—melanoma	3.91e-05	0.000197	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—NRAS—melanoma	3.91e-05	0.000197	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PIK3CA—melanoma	3.88e-05	0.000196	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EGF—melanoma	3.86e-05	0.000195	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HPSE—melanoma	3.86e-05	0.000195	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—KRAS—melanoma	3.84e-05	0.000193	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CUBN—melanoma	3.79e-05	0.000191	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FGF2—melanoma	3.75e-05	0.000189	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HIF1A—melanoma	3.75e-05	0.000189	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—MAPK3—melanoma	3.74e-05	0.000189	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—BRAF—melanoma	3.67e-05	0.000185	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SDHD—melanoma	3.66e-05	0.000185	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—BSG—melanoma	3.66e-05	0.000185	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CSPG4—melanoma	3.66e-05	0.000185	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KDR—melanoma	3.59e-05	0.000181	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IGF1—melanoma	3.58e-05	0.00018	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—MAPK1—melanoma	3.56e-05	0.00018	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—EGFR—melanoma	3.56e-05	0.00018	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GPAM—melanoma	3.55e-05	0.000179	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PIK3CA—melanoma	3.52e-05	0.000178	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MDM2—melanoma	3.51e-05	0.000177	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP17A1—melanoma	3.49e-05	0.000176	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ERBB2—melanoma	3.46e-05	0.000175	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAP2K1—melanoma	3.46e-05	0.000174	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FN1—melanoma	3.45e-05	0.000174	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CD—melanoma	3.44e-05	0.000173	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CB—melanoma	3.41e-05	0.000172	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PIK3CA—melanoma	3.4e-05	0.000172	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOTCH1—melanoma	3.38e-05	0.00017	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—KRAS—melanoma	3.36e-05	0.00017	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CD80—melanoma	3.31e-05	0.000167	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CG—melanoma	3.3e-05	0.000167	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APC—melanoma	3.3e-05	0.000167	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KIT—melanoma	3.3e-05	0.000167	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—NRAS—melanoma	3.3e-05	0.000167	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GNA11—melanoma	3.3e-05	0.000166	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FGF2—melanoma	3.29e-05	0.000166	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCL8—melanoma	3.28e-05	0.000165	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EGF—melanoma	3.26e-05	0.000165	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HRAS—melanoma	3.26e-05	0.000164	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—FASN—melanoma	3.23e-05	0.000163	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CDKN1B—melanoma	3.2e-05	0.000162	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SLC5A5—melanoma	3.18e-05	0.00016	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—AKT1—melanoma	3.17e-05	0.00016	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—MAPK3—melanoma	3.16e-05	0.00016	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CASP3—melanoma	3.14e-05	0.000158	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL2—melanoma	3.14e-05	0.000158	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6—melanoma	3.12e-05	0.000157	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—BRAF—melanoma	3.1e-05	0.000157	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CA—melanoma	3.09e-05	0.000156	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MDM2—melanoma	3.08e-05	0.000155	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GNAQ—melanoma	3.07e-05	0.000155	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CD44—melanoma	3.07e-05	0.000155	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCND1—melanoma	3.06e-05	0.000154	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ERBB2—melanoma	3.03e-05	0.000153	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CTNNB1—melanoma	3.03e-05	0.000153	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IGF1—melanoma	3.02e-05	0.000152	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PLA2G6—melanoma	3.01e-05	0.000152	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—MAPK1—melanoma	3.01e-05	0.000152	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—EGFR—melanoma	3.01e-05	0.000152	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CB—melanoma	2.99e-05	0.000151	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MMP9—melanoma	2.97e-05	0.00015	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CDKN1A—melanoma	2.96e-05	0.000149	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PTEN—melanoma	2.95e-05	0.000149	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP1B1—melanoma	2.94e-05	0.000148	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NFKB1—melanoma	2.94e-05	0.000148	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAP2K1—melanoma	2.92e-05	0.000147	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CD—melanoma	2.9e-05	0.000146	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—AKT1—melanoma	2.88e-05	0.000145	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCL8—melanoma	2.88e-05	0.000145	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CA—melanoma	2.88e-05	0.000145	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HRAS—melanoma	2.86e-05	0.000144	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—KRAS—melanoma	2.84e-05	0.000143	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CDKN1B—melanoma	2.81e-05	0.000142	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGF2—melanoma	2.78e-05	0.00014	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—AKT1—melanoma	2.78e-05	0.00014	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CASP3—melanoma	2.75e-05	0.000139	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL2—melanoma	2.75e-05	0.000139	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6—melanoma	2.74e-05	0.000138	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—VCAN—melanoma	2.71e-05	0.000137	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCND1—melanoma	2.68e-05	0.000135	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—VEGFA—melanoma	2.67e-05	0.000134	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CTNNB1—melanoma	2.65e-05	0.000134	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—STAT3—melanoma	2.64e-05	0.000133	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NRAS—melanoma	2.63e-05	0.000133	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CA—melanoma	2.61e-05	0.000132	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MMP9—melanoma	2.6e-05	0.000131	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MDM2—melanoma	2.6e-05	0.000131	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CDKN1A—melanoma	2.59e-05	0.000131	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PTEN—melanoma	2.59e-05	0.00013	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NFKB1—melanoma	2.57e-05	0.00013	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ERBB2—melanoma	2.56e-05	0.000129	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CB—melanoma	2.53e-05	0.000128	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—AKT1—melanoma	2.52e-05	0.000127	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAPK3—melanoma	2.52e-05	0.000127	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MYC—melanoma	2.45e-05	0.000124	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCL8—melanoma	2.43e-05	0.000123	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ABCB1—melanoma	2.42e-05	0.000122	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HRAS—melanoma	2.42e-05	0.000122	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAPK1—melanoma	2.4e-05	0.000121	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EGFR—melanoma	2.4e-05	0.000121	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CDKN1B—melanoma	2.37e-05	0.00012	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AKT1—melanoma	2.35e-05	0.000118	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—VEGFA—melanoma	2.34e-05	0.000118	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CASP3—melanoma	2.33e-05	0.000117	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL2—melanoma	2.32e-05	0.000117	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—STAT3—melanoma	2.31e-05	0.000117	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6—melanoma	2.31e-05	0.000117	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NRAS—melanoma	2.31e-05	0.000116	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP17A1—melanoma	2.28e-05	0.000115	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KRAS—melanoma	2.27e-05	0.000114	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCND1—melanoma	2.27e-05	0.000114	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CTNNB1—melanoma	2.24e-05	0.000113	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PRKCA—melanoma	2.23e-05	0.000112	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ERCC2—melanoma	2.21e-05	0.000111	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK3—melanoma	2.21e-05	0.000111	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MMP9—melanoma	2.2e-05	0.000111	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CDKN1A—melanoma	2.19e-05	0.000111	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PTEN—melanoma	2.19e-05	0.00011	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NFKB1—melanoma	2.18e-05	0.00011	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GNA11—melanoma	2.16e-05	0.000109	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MYC—melanoma	2.15e-05	0.000108	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AKT1—melanoma	2.13e-05	0.000108	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—FASN—melanoma	2.11e-05	0.000106	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK1—melanoma	2.1e-05	0.000106	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EGFR—melanoma	2.1e-05	0.000106	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CA—melanoma	2.08e-05	0.000105	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC5A5—melanoma	2.08e-05	0.000105	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TP53—melanoma	2.01e-05	0.000102	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GNAQ—melanoma	2.01e-05	0.000101	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CD44—melanoma	2.01e-05	0.000101	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KRAS—melanoma	1.99e-05	0.0001	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—VEGFA—melanoma	1.98e-05	9.96e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—STAT3—melanoma	1.96e-05	9.86e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NRAS—melanoma	1.95e-05	9.84e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HRAS—melanoma	1.93e-05	9.71e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP1B1—melanoma	1.92e-05	9.7e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK3—melanoma	1.87e-05	9.42e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6—melanoma	1.84e-05	9.3e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CA—melanoma	1.83e-05	9.21e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MYC—melanoma	1.82e-05	9.16e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK1—melanoma	1.78e-05	8.97e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EGFR—melanoma	1.78e-05	8.96e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TP53—melanoma	1.77e-05	8.91e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CG—melanoma	1.75e-05	8.81e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AKT1—melanoma	1.7e-05	8.58e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HRAS—melanoma	1.69e-05	8.52e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPARG—melanoma	1.69e-05	8.5e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KRAS—melanoma	1.68e-05	8.47e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6—melanoma	1.62e-05	8.15e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCB1—melanoma	1.58e-05	7.99e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CA—melanoma	1.54e-05	7.78e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CD—melanoma	1.53e-05	7.74e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALB—melanoma	1.52e-05	7.64e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TP53—melanoma	1.49e-05	7.53e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKT1—melanoma	1.49e-05	7.52e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PRKCA—melanoma	1.46e-05	7.35e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ERCC2—melanoma	1.45e-05	7.29e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HRAS—melanoma	1.43e-05	7.2e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6—melanoma	1.37e-05	6.89e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CB—melanoma	1.34e-05	6.75e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTGS2—melanoma	1.33e-05	6.69e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKT1—melanoma	1.26e-05	6.36e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTEN—melanoma	1.16e-05	5.83e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CG—melanoma	1.14e-05	5.76e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPARG—melanoma	1.1e-05	5.56e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CD—melanoma	1e-05	5.06e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALB—melanoma	9.91e-06	5e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CB—melanoma	8.75e-06	4.41e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTGS2—melanoma	8.67e-06	4.37e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CA—melanoma	8.16e-06	4.11e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTEN—melanoma	7.56e-06	3.81e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AKT1—melanoma	6.66e-06	3.36e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CA—melanoma	5.33e-06	2.69e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AKT1—melanoma	4.36e-06	2.2e-05	CbGpPWpGaD
